AI is moving from experimentation to execution across the drug development lifecycle — and the Outsourced Pharma Capacity Update has evolved to match. Now, the Outsourced Pharma Capabilities Update (OPCU), the series shifts beyond open slots to spotlight the technologies, expertise, and specialized fill/finish capabilities CDMOs bring to complex programs.
We’ll focus on where AI delivers results today — from hit-to-lead optimization and analytical development to model-informed process development and digital CPV/QMS — showing how sponsors and CDMOs can reduce cycle times, strengthen quality, and de-risk scale-up. You’ll also gain a practical CDMO readiness checklist and insight into what sponsors will prioritize in 2026: evidence, transparency, and measurable ROI.
Our expanded PARTNER WEEK, organized by capability area, makes it easier to identify the right CDMO strengths — exactly when you need them.
Recent Sessions Available On-Demand
Fill / Finish – 1/27/2026
Large Molecule – 3/10/2026, AM Session
Fill / Finish – 3/10/2026, PM Session
Upcoming OPCU Topics & Times
Small Molecule Drug Substance | 3/11/2026, AM Session
Small Molecule Drug Product | 3/11/2026, PM Session
Cell & Gene | 3/12/2026, AM Session
Analytical Services | 3/12/2026, PM Session
Access more on-demand OPCU recordings and upcoming sessions here.
